Special Master OKs $70M Glaxo Settlement
The $70 million proposed settlement with GlaxoSmithKline plc in an antitrust class action that alleged it defrauded consumers by artificially inflating the prices of various prescription drugs should be approved, the...To view the full article, register now.
Already a subscriber? Click here to view full article